Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 107

1.
2.

Quantitative analysis of human endogenous retrovirus-K transcripts in postmortem premotor cortex fails to confirm elevated expression of HERV-K RNA in amyotrophic lateral sclerosis.

Garson JA, Usher L, Al-Chalabi A, Huggett J, Day EF, McCormick AL.

Acta Neuropathol Commun. 2019 Mar 18;7(1):45. doi: 10.1186/s40478-019-0698-2.

3.

Viral RNA Degradation Makes Urine a Challenging Specimen for Detection of Japanese Encephalitis Virus in Patients With Suspected CNS Infection.

Bharucha T, Sengvilaipaseuth O, Seephonelee M, Vongsouvath M, Vongsouvath M, Rattanavong S, Piorkowski G, Lecuit M, Gorman C, Pommier JD, Garson JA, Newton PN, de Lamballerie X, Dubot-Pérès A.

Open Forum Infect Dis. 2019 Feb 6;6(3):ofz048. doi: 10.1093/ofid/ofz048. eCollection 2019 Mar.

4.

Minor groove binder modification of widely used TaqMan hydrolysis probe for detection of dengue virus reduces risk of false-negative real-time PCR results for serotype 4.

Gray ER, Heaney J, Ferns RB, Sequeira PC, Nastouli E, Garson JA.

J Virol Methods. 2019 Jun;268:17-23. doi: 10.1016/j.jviromet.2019.03.006. Epub 2019 Mar 11.

PMID:
30871982
5.

Detection of bacterial contamination in platelet concentrates from Brazilian donors by molecular amplification of the ribosomal 16S gene.

Viana JD, Ferreira SC, Matana SR, Rossi F, Patel P, Garson JA, Rocha V, Tedder R, Mendrone-Júnior A, Levi JE.

Transfus Med. 2018 Dec;28(6):420-426. doi: 10.1111/tme.12561. Epub 2018 Oct 10.

PMID:
30304760
6.

Development of an improved RT-qPCR Assay for detection of Japanese encephalitis virus (JEV) RNA including a systematic review and comprehensive comparison with published methods.

Bharucha T, Sengvilaipaseuth O, Vongsouvath M, Vongsouvath M, Davong V, Panyanouvong P, Piorkowski G, Garson JA, Newton PN, de Lamballerie X, Dubot-Pérès A.

PLoS One. 2018 Mar 23;13(3):e0194412. doi: 10.1371/journal.pone.0194412. eCollection 2018. Review.

7.

Instability of 8E5 calibration standard revealed by digital PCR risks inaccurate quantification of HIV DNA in clinical samples by qPCR.

Busby E, Whale AS, Ferns RB, Grant PR, Morley G, Campbell J, Foy CA, Nastouli E, Huggett JF, Garson JA.

Sci Rep. 2017 Apr 26;7(1):1209. doi: 10.1038/s41598-017-01221-5.

8.

Digital PCR dynamic range is approaching that of real-time quantitative PCR.

Jones GM, Busby E, Garson JA, Grant PR, Nastouli E, Devonshire AS, Whale AS.

Biomol Detect Quantif. 2016 Nov 2;10:31-33. eCollection 2016 Dec.

9.

Hepatitis C virus quasispecies and pseudotype analysis from acute infection to chronicity in HIV-1 co-infected individuals.

Ferns RB, Tarr AW, Hue S, Urbanowicz RA, McClure CP, Gilson R, Ball JK, Nastouli E, Garson JA, Pillay D.

Virology. 2016 May;492:213-24. doi: 10.1016/j.virol.2016.02.003. Epub 2016 Mar 21.

10.

Detection of Rare Drug Resistance Mutations by Digital PCR in a Human Influenza A Virus Model System and Clinical Samples.

Whale AS, Bushell CA, Grant PR, Cowen S, Gutierrez-Aguirre I, O'Sullivan DM, Žel J, Milavec M, Foy CA, Nastouli E, Garson JA, Huggett JF.

J Clin Microbiol. 2016 Feb;54(2):392-400. doi: 10.1128/JCM.02611-15. Epub 2015 Dec 9.

11.

Proof-of-Principle for Immune Control of Global HIV-1 Reactivation In Vivo.

Smith NM, Mlcochova P, Watters SA, Aasa-Chapman MM, Rabin N, Moore S, Edwards SG, Garson JA, Grant PR, Ferns RB, Kashuba A, Mayor NP, Schellekens J, Marsh SG, McMichael AJ, Perelson AS, Pillay D, Goonetilleke N, Gupta RK.

Clin Infect Dis. 2015 Jul 1;61(1):120-8. doi: 10.1093/cid/civ219. Epub 2015 Mar 16.

12.

Diagnosis of neuroinvasive astrovirus infection in an immunocompromised adult with encephalitis by unbiased next-generation sequencing.

Naccache SN, Peggs KS, Mattes FM, Phadke R, Garson JA, Grant P, Samayoa E, Federman S, Miller S, Lunn MP, Gant V, Chiu CY.

Clin Infect Dis. 2015 Mar 15;60(6):919-23. doi: 10.1093/cid/ciu912. Epub 2015 Jan 7.

13.
14.

Multiple sclerosis-associated retrovirus and related human endogenous retrovirus-W in patients with multiple sclerosis.

Dolei A, Garson JA, Arru G, Clerici M, Germi R, Marche PN, Perron H.

J Neuroimmunol. 2014 Jan 15;266(1-2):87-8. doi: 10.1016/j.jneuroim.2013.11.009. Epub 2013 Dec 6. No abstract available.

PMID:
24355750
15.

Evaluation of an ethidium monoazide-enhanced 16S rDNA real-time polymerase chain reaction assay for bacterial screening of platelet concentrates and comparison with automated culture.

Garson JA, Patel P, McDonald C, Ball J, Rosenberg G, Tettmar KI, Brailsford SR, Pitt T, Tedder RS.

Transfusion. 2014 Mar;54(3 Pt 2):870-8. doi: 10.1111/trf.12256. Epub 2013 May 23.

16.

The digital MIQE guidelines: Minimum Information for Publication of Quantitative Digital PCR Experiments.

Huggett JF, Foy CA, Benes V, Emslie K, Garson JA, Haynes R, Hellemans J, Kubista M, Mueller RD, Nolan T, Pfaffl MW, Shipley GL, Vandesompele J, Wittwer CT, Bustin SA.

Clin Chem. 2013 Jun;59(6):892-902. doi: 10.1373/clinchem.2013.206375. Epub 2013 Apr 9.

17.

Minor groove binder modification of widely used TaqMan probe for hepatitis E virus reduces risk of false negative real-time PCR results.

Garson JA, Ferns RB, Grant PR, Ijaz S, Nastouli E, Szypulska R, Tedder RS.

J Virol Methods. 2012 Dec;186(1-2):157-60. doi: 10.1016/j.jviromet.2012.07.027. Epub 2012 Jul 31. Erratum in: J Virol Methods. 2014 Dec;209:143.

PMID:
22871672
18.

Development of an ethidium monoazide-enhanced internally controlled universal 16S rDNA real-time polymerase chain reaction assay for detection of bacterial contamination in platelet concentrates.

Patel P, Garson JA, Tettmar KI, Ancliff S, McDonald C, Pitt T, Coelho J, Tedder RS.

Transfusion. 2012 Jul;52(7):1423-32. doi: 10.1111/j.1537-2995.2011.03484.x. Epub 2011 Dec 21.

PMID:
22188457
19.

Quantitation of hepatitis delta virus using a single-step internally controlled real-time RT-qPCR and a full-length genomic RNA calibration standard.

Ferns RB, Nastouli E, Garson JA.

J Virol Methods. 2012 Jan;179(1):189-94. doi: 10.1016/j.jviromet.2011.11.001. Epub 2011 Nov 15. Erratum in: J Virol Methods. 2013 Jan;187(1):208.

PMID:
22108292
20.

No evidence of XMRV or related retroviruses in a London HIV-1-positive patient cohort.

Gray ER, Garson JA, Breuer J, Edwards S, Kellam P, Pillay D, Towers GJ.

PLoS One. 2011 Mar 23;6(3):e18096. doi: 10.1371/journal.pone.0018096.

21.

Primer sequence disclosure: a clarification of the MIQE guidelines.

Bustin SA, Benes V, Garson JA, Hellemans J, Huggett J, Kubista M, Mueller R, Nolan T, Pfaffl MW, Shipley GL, Vandesompele J, Wittwer CT.

Clin Chem. 2011 Jun;57(6):919-21. doi: 10.1373/clinchem.2011.162958. Epub 2011 Mar 18. No abstract available.

22.
23.

Disease-associated XMRV sequences are consistent with laboratory contamination.

Hué S, Gray ER, Gall A, Katzourakis A, Tan CP, Houldcroft CJ, McLaren S, Pillay D, Futreal A, Garson JA, Pybus OG, Kellam P, Towers GJ.

Retrovirology. 2010 Dec 20;7(1):111. doi: 10.1186/1742-4690-7-111.

24.

Unreliable real-time PCR analysis of human endogenous retrovirus-W (HERV-W) RNA expression and DNA copy number in multiple sclerosis.

Garson JA, Huggett JF, Bustin SA, Pfaffl MW, Benes V, Vandesompele J, Shipley GL.

AIDS Res Hum Retroviruses. 2009 Mar;25(3):377-8; author reply 379-81. doi: 10.1089/aid.2008.0270. No abstract available.

PMID:
19292592
25.

The MIQE guidelines: minimum information for publication of quantitative real-time PCR experiments.

Bustin SA, Benes V, Garson JA, Hellemans J, Huggett J, Kubista M, Mueller R, Nolan T, Pfaffl MW, Shipley GL, Vandesompele J, Wittwer CT.

Clin Chem. 2009 Apr;55(4):611-22. doi: 10.1373/clinchem.2008.112797. Epub 2009 Feb 26.

26.

Differential susceptibility of PCR reactions to inhibitors: an important and unrecognised phenomenon.

Huggett JF, Novak T, Garson JA, Green C, Morris-Jones SD, Miller RF, Zumla A.

BMC Res Notes. 2008 Aug 28;1:70. doi: 10.1186/1756-0500-1-70.

27.

Whole blood as an alternative to plasma for detection of hepatitis C virus RNA.

Daniel HD, David J, Grant PR, Garson JA, Chandy GM, Abraham P.

J Clin Microbiol. 2008 Nov;46(11):3791-4. doi: 10.1128/JCM.00045-08. Epub 2008 Aug 13.

28.

Quantitation of hepatitis C virus using an in-house real-time reverse transcriptase polymerase chain reaction in plasma samples.

Daniel HD, Grant PR, Garson JA, Tedder RS, Chandy GM, Abraham P.

Diagn Microbiol Infect Dis. 2008 Aug;61(4):415-20. doi: 10.1016/j.diagmicrobio.2008.04.001. Epub 2008 May 16. Erratum in: Diagn Microbiol Infect Dis. 2008 Dec;62(4):479. Grant, Paul R [added]; Garson, Jeremy A [added]; Tedder, Richard S [added].

PMID:
18486403
29.

Application of a novel in vitro selection technique to isolate and characterise high affinity DNA aptamers binding mammalian prion proteins.

Bibby DF, Gill AC, Kirby L, Farquhar CF, Bruce ME, Garson JA.

J Virol Methods. 2008 Jul;151(1):107-15. doi: 10.1016/j.jviromet.2008.03.013. Epub 2008 Apr 23.

PMID:
18433888
30.

Quantification of reverse transcriptase in ALS and elimination of a novel retroviral candidate.

McCormick AL, Brown RH Jr, Cudkowicz ME, Al-Chalabi A, Garson JA.

Neurology. 2008 Jan 22;70(4):278-83. doi: 10.1212/01.wnl.0000297552.13219.b4.

PMID:
18209202
32.

Real-time PCR quantitation of hepatitis B virus DNA using automated sample preparation and murine cytomegalovirus internal control.

Garson JA, Grant PR, Ayliffe U, Ferns RB, Tedder RS.

J Virol Methods. 2005 Jun;126(1-2):207-13.

PMID:
15847939
33.

Detection of serum reverse transcriptase activity in patients with ALS and unaffected blood relatives.

Steele AJ, Al-Chalabi A, Ferrante K, Cudkowicz ME, Brown RH Jr, Garson JA.

Neurology. 2005 Feb 8;64(3):454-8.

PMID:
15699374
34.

Detection of SARS coronavirus in plasma by real-time RT-PCR.

Grant PR, Garson JA, Tedder RS, Chan PK, Tam JS, Sung JJ.

N Engl J Med. 2003 Dec 18;349(25):2468-9. No abstract available.

PMID:
14681520
35.

Commentary on J Clausen's review--endogenous retroviruses in MS.

Garson JA.

Int MS J. 2003 Apr;10(1):20-1. No abstract available.

PMID:
12906766
36.

Development and clinical application of a fully controlled quantitative PCR assay for cell-free cytomegalovirus in human plasma.

Preiser W, Brink NS, Ayliffe U, Peggs KS, Mackinnon S, Tedder RS, Garson JA.

J Clin Virol. 2003 Jan;26(1):49-59.

PMID:
12589834
37.

Development and evaluation of an internally controlled semiautomated PCR assay for quantification of cell-free cytomegalovirus.

Tedder RS, Ayliffe U, Preiser W, Brink NS, Grant PR, Peggs KS, Mackinnon S, Kreig-Schneider F, Kirk S, Garson JA.

J Med Virol. 2002 Apr;66(4):518-23.

PMID:
11857531
38.

Evaluation of diagnostic methods for the detection of cytomegalovirus in recipients of allogeneic stem cell transplants.

Preiser W, Bräuninger S, Schwerdtfeger R, Ayliffe U, Garson JA, Brink NS, Franck S, Doerr HW, Rabenau HF.

J Clin Virol. 2001 Jan;20(1-2):59-70. Erratum in: J Clin Virol 2001 Dec;23(1-2):117.

PMID:
11163584
39.

GBV-C prevalence in blood donors and transfusion recipients in South East England.

Whitby K, Ferns RB, Garson JA, Bailey M, Howell D, Barbara JA, Tedder RS.

Vox Sang. 2000;79(4):246. No abstract available.

PMID:
11155078
40.

Infrequency of detection of particle-associated MSRV/HERV-W RNA in the synovial fluid of patients with rheumatoid arthritis.

Gaudin P, Ijaz S, Tuke PW, Marcel F, Paraz A, Seigneurin JM, Mandrand B, Perron H, Garson JA.

Rheumatology (Oxford). 2000 Sep;39(9):950-4.

PMID:
10986298
41.

Detection of reverse transcriptase activity in the serum of patients with motor neurone disease.

Andrews WD, Tuke PW, Al-Chalabi A, Gaudin P, Ijaz S, Parton MJ, Garson JA.

J Med Virol. 2000 Aug;61(4):527-32.

PMID:
10897073
42.
43.

Effects of handling and storage of blood on the stability of hepatitis C virus RNA: implications for NAT testing in transfusion practice.

Grant PR, Kitchen A, Barbara JA, Hewitt P, Sims CM, Garson JA, Tedder RS.

Vox Sang. 2000;78(3):137-42.

PMID:
10838513
44.

Absence of human retrovirus 5 in French patients with rheumatoid arthritis: comment on the article by Griffiths et al.

Gaudin P, Moutet F, Tuke PW, Garson JA.

Arthritis Rheum. 1999 Nov;42(11):2492-4. No abstract available.

45.

A second outbreak of hepatitis C virus infection from anti-D immunoglobulin in Ireland.

Smith DB, Lawlor E, Power J, O'Riordan J, McAllister J, Lycett C, Davidson F, Pathirana S, Garson JA, Tedder RS, Yap PL, Simmonds P.

Vox Sang. 1999;76(3):175-80.

PMID:
10341334
46.

Suramin blocks hepatitis C binding to human hepatoma cells in vitro.

Garson JA, Lubach D, Passas J, Whitby K, Grant PR.

J Med Virol. 1999 Mar;57(3):238-42.

PMID:
10022794
47.

Lack of evidence for HTLV tax-rex DNA in motor neurone disease.

Andrews WD, Al-Chalabi A, Garson JA.

J Neurol Sci. 1997 Dec 9;153(1):86-90.

PMID:
9455984
48.

Detection of virion-associated MSRV-RNA in serum of patients with multiple sclerosis.

Garson JA, Tuke PW, Giraud P, Paranhos-Baccala G, Perron H.

Lancet. 1998 Jan 3;351(9095):33. No abstract available.

PMID:
9433428
49.

Combination therapy with interferon alpha and ribavirin for chronic hepatitis C virus infection in thalassaemic patients.

Telfer PT, Garson JA, Whitby K, Grant PR, Yardumian A, Hoffbrand AV, Wonke B.

Br J Haematol. 1997 Sep;98(4):850-5.

PMID:
9326177
50.

Virological, biochemical and histological effects of human lymphoblastoid interferon in Swedish patients with chronic hepatitis C.

Garson JA, Uhnoo I, Whitby K, Braconier JH, Deaville R, Duberg A, Wallmark E, Wiström J, Goldin RD, Spacey B.

J Viral Hepat. 1997 Sep;4(5):325-31.

PMID:
9310931

Supplemental Content

Loading ...
Support Center